|
Peptide Array for Profiling of Autoantibodies in Non-small Cell Lung Cancer
|
1R43CA132554-01
|
$165,288
|
$165,288
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
SBIR PHASE I, TOPIC 239 HIGH-THROUGHPUT SELECTION OF APTAMERS AGAINST CANCER BIOM
|
N43CO700033-000
|
$149,944
|
$149,944
|
POTHUKUCHY, ARTI
|
ACCACIA INTERNATIONAL INC
|
|
SBIR PHASE I : ANTIBODY MICROARRAY FOR CANCER BIOMARKER DETECTION
|
N43CN700035-000
|
$145,229
|
$145,229
|
ZHOU, XICHUN
|
ADA TECHNOLOGIES, INC.
|
|
A Novel Needle-Based X-Ray System
|
5R44CA112683-03
|
$380,000
|
$380,000
|
Gutman, George
|
ADVANCED X-RAY TECHNOLOGY, INC.
|
|
SBIR PHASE I: ANTIBODY ARRAY FOR CANCER DETECTION
|
N43CN700065-000
|
$150,000
|
$150,000
|
BOCHKARIOV, DMITRY
|
ADVANSTA INC
|
|
Aerosol Therapy for Lung Cancer
|
5R44CA096409-03
|
$371,115
|
$371,115
|
Hansen, Brian
|
AEROPHASE, INC.
|
|
High Resolution Digital Imaging X-ray Detectors
|
5R42CA110192-04
|
$344,805
|
$344,805
|
Batinica, Gregory
|
AGUILA TECHNOLOGIES, INC.
|
|
Computer-aided tool for diagnostic breast ultrasound
|
4R44CA112858-02
|
$449,607
|
$449,607
|
Galperin, Michael
|
ALMEN LABORATORIES, INC.
|
|
Integrated Technology for microRNA-based Diagnostic Assays
|
1R43CA128123-01
|
$328,413
|
$328,413
|
LATHAM, GARY
|
AMBION DIAGNOSTICS, INC.
|
|
Multiplex Detection of Mutations in Myeloproliferative Disorder and Leukemia Pati
|
1R43CA130501-01
|
$256,027
|
$256,027
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
Improving colonoscopic miss rate by real time microvascular blood analysis
|
1R42CA130508-01A1
|
$100,007
|
$100,007
|
ROY, HEMANT
|
AMERICAN BIOOPTICS, LLC
|
|
Orthotopic models of tumor angiogenesis and blood flow
|
5R44CA099258-03
|
$374,848
|
$374,848
|
YANG, MENG
|
ANTICANCER, INC.
|
|
Dual-color tumor-host imaging models
|
5R44CA103563-03
|
$375,784
|
$375,784
|
YANG, MENG
|
ANTICANCER, INC.
|
|
Improving the Transfer of ERK siRNA Constructs Using Nanoporous Silica
|
1R41CA126155-01A1
|
$100,000
|
$100,000
|
Landry, Christopher
|
APOLLO SRI, LLC
|
|
Drug-eluting Tracheobronchial Stents to treat Obstruction caused by Lung Cancer
|
1R43CA119503-01A2
|
$100,000
|
$100,000
|
SHENOY, NARMADA
|
ARAVASC, INC.
|
|
Integrated Image-Guided Ultrasound Ablation System for Cancer Management
|
5R43CA124283-02
|
$161,423
|
$161,423
|
Barthe, Peter
|
ARDENT SOUND, INC.
|
|
Mapping epigenetic modifications at the nanoscale: Aptamers for microscopy
|
1R21CA125510-01A1
|
$181,000
|
$181,000
|
LINDSAY, STUART
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Portable Imaging Device for Prostate Cancer Detection
|
5R44CA082620-05
|
$1,000,000
|
$1,000,000
|
Sarvazyan, Armen
|
ARTANN LABORATORIES, INC.
|
|
IMAGING NETWORK FOR BREAST CANCER MASS SCREENING
|
5R44CA091392-05
|
$206,640
|
$206,640
|
Sarvazyan, Armen
|
ARTANN LABORATORIES, INC.
|
|
A Proteomics Platform for Quantitative, Ultra-High Throughput, and Ultra-Sensitiv
|
3R21CA126191-01S1
|
$30,000
|
$30,000
|
SMITH, RICHARD
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Multiplexed Methods for the Study of Chromosomal Aberrations in Cancer
|
1R33CA114151-01A1
|
$230,510
|
$230,510
|
MILOSAVLJEVIC, ALEKSANDAR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Diagnostic Cancer Imaging using NIR Fluorescent Agents and FDPM
|
5R01CA112679-12
|
$496,564
|
$496,564
|
SEVICK-MURACA, EVA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Arrayed Microfluidic Device for Reconstituted Tissue Assays
|
9R44CA133909-02
|
$528,122
|
$528,122
|
HAYES, STEVEN
|
BELLBROOK LABS, LLC
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-02
|
$333,543
|
$333,543
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Blood Flow MRI for Monitoring of Renal Cell Carcinoma
|
5R21CA121570-02
|
$292,999
|
$292,999
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spatially Modulated Near-Infrared Light for Image-Guided Cancer Surgery
|
1R21CA129758-01
|
$371,307
|
$371,307
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-03
|
$1,241,997
|
$1,241,997
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A novel biotherapeutic treatment for prostate cancer
|
1R43CA130228-01
|
$145,306
|
$145,306
|
CHOI, ANTHONY
|
BEXION PHARMACEUTICALS, INC.
|
|
SBIR TOPIC 229 A ROBUST AND RIGOROUS PHARMACODYNAMIC ASSAY FOR AKT
|
N43CM700049-000
|
$149,947
|
$149,947
|
SHUGUI HUANG, FRANK
|
BIOASSAY SYSTEMS LLC
|
|
MRI-GUIDED ROBOTIC BREAST CANCER INTERVENTIONS
|
1R43CA126098-01
|
$157,425
|
$157,425
|
Larson, Blake
|
BIOENGINEERING, INC.
|
|
Bioscience Research Integration Software Platform
|
4R42CA105217-02
|
$819,941
|
$819,941
|
Bova, George
|
BIOFORTIS, INC.
|
|
Geostatistical software for the space-time analysis of health disparities
|
5R44CA110281-03
|
$390,905
|
$390,905
|
GOOVAERTS, PIERRE
|
BIOMEDWARE
|
|
Cancer Clustering for Residential Histories
|
2R44CA117171-02
|
$374,999
|
$374,999
|
Jacquez, Geoffrey
|
BIOMEDWARE
|
|
Conformal Heat and Brachytherapy Surface Applicator
|
5R44CA104061-03
|
$382,847
|
$382,847
|
SCHLORFF, JAIME
|
BIONIX DEVELOPMENT CORPORATION
|
|
Data acquisition system for noninvasive cancer detection
|
5R42CA106193-04
|
$280,988
|
$280,988
|
Gorbovitski, Boris
|
BIOPHOTONICS CORPORATION
|
|
Long Acting VEGF BInding Proteins for Treating Cancer
|
5R44CA099217-03
|
$335,148
|
$335,148
|
Cox, George
|
BOLDER BIOTECHNOLOGY, INC.
|
|
Optical Spectroscopy for Management of Cancer Treatment
|
5U54CA104677-05
|
$1,087,460
|
$1,087,460
|
BIGIO, IRVING
|
BOSTON UNIVERSITY
|
|
Ultrasensitive Nanomechanical Sensors for Early Detection of Breast Cancer
|
5R03CA125867-02
|
$78,894
|
$78,894
|
MOHANTY, PRITIRAJ
|
BOSTON UNIVERSITY
|
|
Dynamic contrast-enhanced MRI of pulmonary nodule at 3T
|
5R21CA116271-02
|
$160,328
|
$160,328
|
HATABU, HIROTO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image Guided Therapy
|
2P01CA067165-09A2
|
$1,099,994
|
$1,099,994
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Visualization of Multi-Resolution Reconstructions Using Interactive Stereoscopy
|
1R21CA123057-01A1
|
$201,870
|
$201,870
|
SITEK, ARKADIUSZ
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Enabling Technologies for MRI-Guided Prostate Interventions
|
5R01CA111288-02
|
$727,241
|
$727,241
|
TEMPANY, CLARE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative C-arm Fluoroscopy - Prostate Brachytherapy
|
5R44CA099374-03
|
$520,901
|
$520,901
|
BURDETTE, EVERETTE
|
BURDETTE MEDICAL SYSTEMS, INC.
|
|
Screening Pretest for HNPCC
|
5R44CA090122-03
|
$360,614
|
$360,614
|
FIELDS, JEREMY
|
CA*TX, INC.
|
|
Integrated Top-Down/Bottom-Up Comprehensive Proteomics
|
5R44CA107988-04
|
$843,512
|
$843,512
|
Balgley, Brian
|
CALIBRANT BIOSYSTEMS, INC.
|
|
Cellularly resolved molecular pathway assessment in biopsies via spectral imaging
|
1R44CA130026-01
|
$227,868
|
$227,868
|
LEVENSON, RICHARD
|
CAMBRIDGE RESEARCH AND INSTRUMENTATION
|
|
Spectral imaging for automated malignant blast counting
|
5R44CA088684-07
|
$1,006,481
|
$1,006,481
|
LEVENSON, RICHARD
|
CAMBRIDGE RESEARCH AND INSTRUMENTATION
|
|
Molecular Imaging and therapy of Solid Tumors with Specific Nuclear Nanoparticle
|
N02CM027031-000
|
$384
|
$384
|
UNKNOWN, UNKNOWN
|
CAPITAL TECHNOLOGY INFORMATION
|
|
CANCER THERAPY EVALUATION PROGRAM'S INFORMATICS AND COMPUTER SUPPORT
|
N02CM027021-020
|
$8,500,000
|
$8,500,000
|
KIDWILER, RACHEL
|
CAPITAL TECHNOLOGY INFORMATION SERVICES,
|
|
TITLE: PATIENT-REPORTED OUTCOMES (PRO) MANAGEMENT SYSTEM. SBIR TOPIC 212.
|
N44PC700046-000
|
$749,917
|
$749,917
|
YANG, DERSHUNG
|
CARACAL INC
|
Total relevant funding to Bioengineering for this search: $192,024,685
|